2 completed. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Bempedoic acid 180 mg tablet: new trials by email Literature Review of Bempedoic acid 180 mg tablet trials Research Report on Bempedoic acid 180 mg tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan Bempedoic acid 180 mg tablet - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 4 | Completed | Daiichi Sankyo | 180 | 2025-04-01 | 2025-12-08 |
| Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo Bempedoic acid 180 mg tablet, Matching placebo tablet - Cardiovascular Diseases, Statin Adverse Reaction | Phase 3 | Completed | Esperion Therapeutics, Inc. | 13970 | 2016-12-22 | 2024-01-03 |
Cardiovascular Diseases (1) · Hyperlipoproteinemia Type II (1)
Daiichi Sankyo (1) · Esperion Therapeutics, Inc. (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Denmark (1) · Estonia (1) · Germany (1) · Hungary (1)
PMID 37929602, PMID 38061370, PMID 38960508, PMID 39921511, PMID 39939212, PMID 40833562, PMID 41391972, PMID 41923439, PMID 42134976, PMID 42201706